###begin article-title 0
###xml 103 108 <span type="species:ncbi:4932">yeast</span>
Genome-wide screening for genes whose deletions confer sensitivity to mutagenic purine base analogs in yeast
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 269 286 269 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 481 506 481 506 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 269 285 <span type="species:ncbi:562">Escherichia coli</span>
###xml 475 480 <span type="species:ncbi:4932">yeast</span>
###xml 481 505 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 697 702 <span type="species:ncbi:4932">yeast</span>
N-hydroxylated base analogs, such as 6-hydroxylaminopurine (HAP) and 2-amino-6-hydroxylaminopurine (AHA), are strong mutagens in various organisms due to their ambiguous base-pairing properties. The systems protecting cells from HAP and related noncanonical purines in Escherichia coli include specialized deoxyribonucleoside triphosphatase RdgB, DNA repair endonuclease V, and a molybdenum cofactor-dependent system. Fewer HAP-detoxification systems have been identified in yeast Saccharomyces cerevisiae and other eukaryotes. Cellular systems protecting from AHA are unknown. In the present study, we performed a genome-wide search for genes whose deletions confer sensitivity to HAP and AHA in yeast.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 27 32 <span type="species:ncbi:4932">yeast</span>
We screened the library of yeast deletion mutants for sensitivity to the toxic and mutagenic action of HAP and AHA. We identified novel genes involved in the genetic control of base analogs sensitivity, including genes controlling purine metabolism, cytoskeleton organization, and amino acid metabolism.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 40 45 <span type="species:ncbi:4932">yeast</span>
We developed a method for screening the yeast deletion library for sensitivity to the mutagenic and toxic action of base analogs and identified 16 novel genes controlling pathways of protection from HAP. Three of them also protect from AHA.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 391 392 391 392 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 393 394 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 679 687 679 687 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 728 729 728 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 730 731 730 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 679 686 <span type="species:ncbi:562">E. coli</span>
The accurate replication and repair of genetic material, which is a prerequisite for normal functioning of the eukaryotic genome and the prevention of cancer, relies on coordinated and faithful DNA synthesis. One important mechanism that ensures a high fidelity of DNA replication is a "cleansing" of the DNA precursor pool from deoxyribonucleoside triphosphates containing a modified base [1-4]. Such modified bases may have ambiguous base-pairing properties that will result in a high mutagenic activity after their incorporation into DNA during replication. A classic example of the detoxification mechanism is the elimination of dUTP and 8-oxo-dGTP from the dNTP pool by the E. coli dUTPase and MutT proteins, respectively [1,5].
###end p 9
###begin p 10
###xml 129 130 129 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 131 132 131 132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 375 376 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1</xref>
###xml 516 517 516 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 518 520 518 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 99 104 <span type="species:ncbi:4932">yeast</span>
Purine analogs 6-hydroxyaminopurine (HAP) and 2-amino-HAP (AHA) are powerful mutagens in bacteria, yeast, and higher eukaryotes [6,7]. It has been suggested that HAP-deoxyriboside-triphosphate (dHAPTP) is a possible endogenous contaminant of nucleotide pools under peroxyl radical stress [8]. HAP and AHA closely resemble the natural purines, hypoxanthine and xanthine (Fig. 1), and therefore, could be exploited to investigate the mechanism preventing mutations that are caused by non-canonical purine nucleotides [9-11].
###end p 10
###begin p 11
Chemical structures of HAP and AHA and natural purine bases.
###end p 11
###begin p 12
###xml 223 225 223 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 226 228 226 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 572 574 572 574 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 635 643 635 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 644 646 644 646 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1067 1072 1067 1072 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HAM1 </italic>
###xml 1078 1080 1078 1080 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1116 1121 1116 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HAM1 </italic>
###xml 1201 1203 1201 1203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1268 1270 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1387 1389 1387 1389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1677 1679 1677 1679 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1680 1682 1680 1682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 258 263 <span type="species:ncbi:4932">yeast</span>
###xml 635 642 <span type="species:ncbi:562">E. coli</span>
###xml 1037 1042 <span type="species:ncbi:4932">yeast</span>
###xml 1193 1199 <span type="species:ncbi:9606">humans</span>
###xml 1485 1490 <span type="species:ncbi:4932">yeast</span>
It was proposed that purine salvage enzymes convert base analogs to the corresponding deoxyribonucleoside triphosphates, which are misincorporated or misreplicated during DNA synthesis, resulting in induction of mutations [12,13]. HAP-induced mutagenesis in yeast is elevated in strains with defects in proofreading activity of replicative DNA polymerases [14,15] and does not depend on excision, mutagenic recombination, and mismatch repair systems [14-16]. We have described several systems protecting cells from the mutagenic and inhibitory effects of HAP (see review [16]). One is the novel molybdenum cofactor-dependent system in E. coli [17]. It has yet to be determined if a similar system exists in higher eukaryotes. Another, versatile HAP-detoxification pathway relies upon the action of triphosphatase, Ham1p, which hydrolyze HAP-containing ribo- and deoxyribo-nucleotides to nucleoside monophosphates, and which prevent incorporation of base analog into DNA and RNA. We initially described the elevated sensitivity to HAP in yeast due to mutations in the HAM1 gene [18]. When we cloned and sequenced the HAM1 gene, we found that it has homologs in many organisms, from bacteria to humans [13], and proposed that the gene might code for new triphosphatase [16]. Then, the crystal structure of the Ham1p homologue from a thermostable bacterium (protein Mj0226) was determined [19]. It was found that the Ham1p ternary structure has common features with MutT. Homologs of the yeast Ham1p from other organisms possessed triphosphatase activity on dITP, ITP, XTP, and dHAPTP substrates (Kozmin and Pavlov, unpublished; Burgis and Cunnigham, personal communication; and [19-21]).
###end p 12
###begin p 13
###xml 115 117 115 117 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 145 150 145 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 260 262 260 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 103 108 <span type="species:ncbi:4932">yeast</span>
There are additional, less thoroughly studied, factors modulating purine base analogues mutagenesis in yeast (see [16] for review). For example, aah1 mutants are sensitive to HAP, suggesting that adenine deaminase Aah1p may deaminate HAP base to hypoxanthine [16].
###end p 13
###begin p 14
###xml 257 259 257 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 451 453 451 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 454 456 454 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 494 496 494 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 777 779 777 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 157 162 <span type="species:ncbi:4932">Yeast</span>
###xml 250 255 <span type="species:ncbi:4932">yeast</span>
###xml 631 636 <span type="species:ncbi:4932">yeast</span>
###xml 657 662 <span type="species:ncbi:9606">human</span>
In the present study, we carried out a genome-wide search for HAP and AHA sensitive mutants. The release of several complete sets of deletion mutants by the Yeast Deletion Project provides a powerful approach for different types of genome screens in yeast [22]. Haploid and diploid strains have already been used to detect new genes controlling sensitivity to different agents such as UV, ionising radiation, iron, and methyl methane sulfonate (MMS) [23-27], as well as spontaneous mutability [28]. This approach, when combined with other genomics approaches, helps to establish the biological functions of uncharacterized ORFs in yeast, many of which have human orthologs. This approach also allows us to decipher the network responses to endogenous and environmental stress [29]. The present study is the first systematic, genome-wide search for the mutations conferring sensitivity to mutagenic purine base analogs.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
Development of the screening method
###end title 16
###begin p 17
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 225 230 225 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 236 237 236 237 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 291 292 291 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 502 504 502 504 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 45 50 <span type="species:ncbi:4932">yeast</span>
###xml 333 338 <span type="species:ncbi:4932">yeast</span>
To develop a useful method for searching the yeast mutants sensitive to base analogs, we calibrated the experimental conditions using the wild-type strain, BY4742, and two previously described HAP-sensitive mutants, ham1 and aah1 (see [6,16]), created on BY4742 background. As shown in Fig. 2 and described in Materials and Methods, yeast were grown in a 96-well microtiter plate and then transferred, using a multiprong replicator device, to YPD plates containing base analogs. An induction of the Canr mutants was monitored by replica-plating to the minimal-medium plates containing L-canavanine.
###end p 17
###begin p 18
###xml 41 46 <span type="species:ncbi:4932">yeast</span>
Scheme of the protocol for screening the yeast deletions library for base analog sensitivity and induced mutagenesis.
###end p 18
###begin p 19
###xml 34 35 34 35 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 60 61 60 61 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 278 283 278 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 287 292 287 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 394 396 394 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 401 403 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 484 486 483 485 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 546 548 545 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 720 722 717 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 816 818 812 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 828 830 824 826 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 983 985 978 980 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 990 992 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
The results are presented in Fig. 3. The left panel of Fig. 3 shows the induction of canavanine-resistant mutants by HAP and AHA; and the right panel represents the survival of the tested strains on YPD plates in the presence of base analogs. In the wild-type strain, as in the ham1 and aah1 mutants, 1-3 spontaneous canavanine-resistant colonies per spot arise in the absence of mutagen (Fig. 3A and 3B, left panel). In our experimental conditions, 1 mug/ml of HAP did not induce Canr mutants in the wild-type strain. A moderate induction of Canr clones (fewer than ten per spot) was observed at 10 mug/ml of HAP and a very strong HAP-induced mutagenesis was observed in the wild-type strain at 100 mug/ml of HAP (Fig. 3A, left panel). For comparison, 100 mug/ml of AHA were only moderately mutagenic (compare Fig. 3A and Fig. 3E, left panel). Furthermore, both HAP and AHA did not affect the viability of the wild-type strain, even at the maximal concentration of 100 mug/ml (Fig. 3A and 3E, right panel).
###end p 19
###begin p 20
###xml 7 12 7 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 47 49 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 208 210 206 208 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 215 217 213 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 294 299 292 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 383 385 380 382 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 611 616 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 629 631 624 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 760 765 755 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 789 791 784 786 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 822 824 817 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 903 908 898 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 1055 1060 1049 1054 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 1253 1258 1245 1250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 1382 1387 1372 1377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
In the ham1 strain, 1 mug/ml of HAP induced Canr mutants with the similar frequency that was observed in the wild-type strain at 2 orders in magnitude higher concentration of analog, 100 mug/ml (compare Fig. 3A and 3B, left panel, phenotype of hypermutability, HM). The hypersensitivity of the ham1 mutant to the toxic action of HAP was clearly detectable at 100 mug/ml of HAP (Fig. 3B, right panel). We will refer later to this phenotype as hypersensitivity, HS. Note that a reduction of the number of canavanine-resistant clones at 10 and 100 mug/ml of HAP, in comparison with 1 mug/ml of HAP observed in the ham1 mutant (Fig. 3B, left panel, another manifestation of hypersensitivity phenotype, HS), is also due to a dramatic decrease of survival. When the aah1 mutant was tested (Fig. 3B, second row, for HAP and Fig. 3F, first row, for AHA), the drop of viability was less severe than that for the ham1 mutant (phenotype of elevated sensitivity, S). HAP-induced mutagenesis was detectable at a low dose of 1 mug/ml, but was much less compared to the ham1 mutant (phenotype of elevated mutability, M). Mutagenesis was somewhat stronger at the dose 10 mug/ml and was not seen at 100 mug/ml (another manifestation of elevated sensitivity, S). For the aah1 mutant, AHA-induced mutagenesis was moderate at the dose of 10 mug/ml and very strong at a concentration of 100 mug/ml. The aah1 mutant exemplified what we expect to observe for mutants moderately sensitive to both HAP and AHA. These data suggested that the procedure we devised for micro-titre plate format is effective for the detection of mutants with altered parameters of HAP and AHA sensitivity and mutability.
###end p 20
###begin p 21
###xml 0 117 0 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Results of the screening of the yeast deletion library for elevated mutagenesis and sensitivity in micro-titer plates</bold>
###xml 32 37 <span type="species:ncbi:4932">yeast</span>
Results of the screening of the yeast deletion library for elevated mutagenesis and sensitivity in micro-titer plates. Left panel - Mutagenesis on selective plates with canavanine. Right panel - The estimation of the number of colony-forming units on YPD medium.
###end p 21
###begin title 22
Screening of the deletion strains library
###end title 22
###begin p 23
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 347 348 347 348 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 706 707 706 707 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 752 757 752 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 774 780 774 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12 </italic>
###xml 784 788 784 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade2</italic>
###xml 895 896 895 896 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 907 908 907 908 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1048 1054 1047 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12 </italic>
###xml 1090 1095 1089 1094 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ham1 </italic>
###xml 1222 1224 1221 1223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1242 1243 1241 1242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1267 1272 1266 1271 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade2 </italic>
###xml 1301 1306 1300 1305 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 1320 1321 1319 1320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 1427 1428 1426 1427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 16 21 <span type="species:ncbi:4932">yeast</span>
We screened the yeast deletion strains library as described above. After an initial screening of 4,823 deletion strains, 43 mutants strains appeared to affect base analog-induced killing or mutagenesis. However, in subsequent testing of candidate strains in same type of plate tests, we have confirmed HAP-sensitivity of 16 mutants (Fig. 3, Table 1, column 4, where we refer to phenotypes of mutants according to abbreviations described in previous section). Next, we examined the mutability and survival of these 16 mutants in quantitative tests with HAP (see Materials and Methods). Based on the results of these two types of tests, we categorize HAP-sensitive strains in three groups, as shown in Table 1. Group I comprises, in addition to ham1 and aah1 strains, mutants ade12 and ade2. These strains were hypersensitive to the mutagenic and lethal action of HAP in both types of tests (Fig. 3 and Table 1, columns 4-6). Strains of this group were sensitive to the low doses (1 and/or 10 mug/ml) of HAP, in contrast to the wild-type strain. The ade12 mutant was almost as mutable as the ham1 strain, but the hypermutability could only be demonstrated in a quantitative test, due to poor plating efficiency (compare Fig 3B, row 3 and Table 1, column 5, row 3). The ade2 mutant was as mutable as the aah1 mutant (Table 1). Deletion mutants of the first group showed variable degree of sensitivity to HAP-induced killing Table 1, column 6).
###end p 23
###begin p 24
HAP-sensitivity of the mutants selected in our screening.
###end p 24
###begin p 25
###xml 0 8 0 3 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8224;- </sup>
dagger- HM - hypermutable, M - more mutable than wild-type, HS - hypersensitive, S - more sensitive than wild-type, see first paragraph od the Results Section for the explanation.
###end p 25
###begin p 26
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink"># </sup>
# - 25 mug/ml
###end p 26
###begin p 27
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">1 </sup>
1 - 'DNA' - includes genes involved in the control of DNA precursor metabolism, purine salvage, DNA repair.
###end p 27
###begin p 28
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2 </sup>
2 - 'Cell' - includes genes involved in cytoskeleton organization, cell walls and organelles.
###end p 28
###begin p 29
###xml 0 2 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
3 - 'Metabolic' - includes genes involved in general metabolic pathways.
###end p 29
###begin p 30
* - These mutants were also sensitive to the mutagenic or toxic effect of AHA (see Fig. 3).
###end p 30
###begin p 31
###xml 0 8 0 2 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#176; </sup>
degrees - small difference from the wild-type strain was reproducible and statistically significant by Wilcoxon-Mann-Whitney test.
###end p 31
###begin p 32
###xml 296 298 296 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 362 364 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 372 373 371 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 429 431 428 430 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 653 654 650 651 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 790 834 787 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">vip1, vid27, ade1, ade5,7, ade6, ade8, ipk1 </italic>
###xml 838 845 835 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rim101 </italic>
###xml 856 857 853 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 912 914 909 911 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 1083 1085 1079 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 1096 1103 1092 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yjl055w</italic>
###xml 1105 1112 1101 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ygr035c</italic>
###xml 1118 1123 1114 1119 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade3 </italic>
###xml 1174 1176 1170 1172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
Eleven mutants fall into Group II. Mutants of this class were sensitive to the mutagenic effect of HAP, but their growth was not severely inhibited on HAP-containing medium. As a result, there is a smaller difference, in comparison to mutants of the group I, or no difference in the number of Canr mutants induced by 10 and 100 mug/ml of HAP in spot-tests (Fig. 3C, Table 1, column 4). These strains produced some HAP-induced Canr mutants at 10 mug/ml of HAP, whereas the parental strain was non-mutable at this HAP concentration. We also did not detect any substantial drops of viability after growth in liquid media containing 25 mug/ml of HAP (Table 1, column 6). Group II was not homogeneous in respect to HAP mutability and sensitivity. The six most sensitive mutants in the group are vip1, vid27, ade1, ade5,7, ade6, ade8, ipk1 and rim101 (see Table 1). These mutants showed a decrease in the number of Canr mutants in a qualitative test when concentration of HAP increased ten-fold (up to 100 mug/ml), which is an indication of some cell death at very high doses of HAP (Fig. 3C). Mutants yjl055w, ygr035c, and ade3 were more resistant to HAP, since the number of Canr colonies was similar at 10 and 100 mug/ml of HAP. As could be seen from the results of quantitative assay, mutant classification is quite conditional and there is substantial variation in responses between mutants of the Group II, but all of them were more mutable that the wild-type strain.
###end p 32
###begin p 33
###xml 36 46 36 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">she4, trp2</italic>
###xml 52 63 52 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yml013c-a; </italic>
###xml 149 151 149 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 162 163 162 163 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 202 212 202 212 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yml013c-a </italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trp2 </italic>
###xml 318 319 318 319 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 326 331 326 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">she2 </italic>
###xml 498 503 <span type="species:ncbi:4932">yeast</span>
Finally, Group III includes mutants she4, trp2, and yml013c-a; which were sensitive to HAP-induced killing, but not to HAP-induced mutagenesis (Fig. 3D and Table 1, column 6). In quantitative tests the yml013c-a and trp2 mutants were even less sensitive to the mutagenic action of HAP than the wild-type strain (Table 1). The she2 mutant was slightly more mutable that the wild-type strain only in quantitative test. The existence of such a type of mutants suggests that the toxic effect of HAP in yeast may be not only due to the induction of lethal mutations, but also due to inhibition of certain metabolic pathways.
###end p 33
###begin p 34
###xml 78 82 78 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1</italic>
###xml 84 89 84 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12</italic>
###xml 95 103 95 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yjl055w </italic>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 226 231 226 231 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 235 242 235 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yjl055w</italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de12 </italic>
###xml 460 465 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 469 477 468 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yjl055w </italic>
###xml 510 516 509 515 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12 </italic>
###xml 550 555 549 554 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 559 567 558 566 <italic xmlns:xlink="http://www.w3.org/1999/xlink">yjl055w </italic>
###xml 659 662 657 660 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7 </sup>
###xml 674 676 672 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
###xml 753 759 751 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12 </italic>
###xml 775 777 773 775 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
In the present study, we have also characterized three AHA-sensitive mutants, aah1, ade12, and yjl055w (Fig. 3E and 3F). Remarkably, all of these mutants were also sensitive to HAP (Fig. 3C and Table 1). Two of those mutants, aah1 and yjl055w, were AHA-hypermutable; whereas ade12 strain did not mutate in the presence of AHA, but was sensitive to AHA-induced killing. In a quantitative test, 50 mug/ml of AHA did not inhibit survival of the wild-type strain, aah1 and yjl055w strains; whereas survival of the ade12 mutant was reduced to 50%. In the aah1 and yjl055w strains, 50 mug/ml of AHA induced canavanine-resistant mutants with the frequencies 120 x 10-7 and 270 x 10-7, respectively, that was 4-9-folds higher than observed in the wild-type and ade12 strains (30 x 10-7, in both strains).
###end p 34
###begin title 35
Discussion
###end title 35
###begin p 36
###xml 160 161 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 496 497 496 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 508 509 508 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 991 1008 991 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1</xref>
###xml 115 120 <span type="species:ncbi:4932">yeast</span>
###xml 263 268 <span type="species:ncbi:4932">yeast</span>
In this study, we elaborated the technology for testing base analog-induced mutability and killing of thousands of yeast strains in microtiter format (see Fig. 2). We found that the method is quite sensitive and reliable. Next, we screened the library of haploid yeast strains carrying deletions in all nonessential ORFs for the sensitivity to mutagenic base analogs HAP and AHA. We have found 16 novel HAP-sensitive mutants that fall into several groups, based on the sensitivity profiles (Fig. 3 and Table 1). One group comprises the mutants that are HAP-hypermutable and grow poorly in the presence of HAP. Another class comprises strains with elevated HAP-mutability that grow normally on medium containing HAP. Finally, the third group includes the mutants sensitive to HAP-induced killing, but not to HAP-induced mutagenesis. We have also isolated three AHA-sensitive mutants. All of them were HAP sensitive as well. We summarized the properties of the genes found in our screening in Additional file 1.
###end p 36
###begin p 37
###xml 134 142 134 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YML013c-</italic>
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12</italic>
###xml 279 281 279 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 282 284 282 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 380 390 380 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">YML013c-a </italic>
###xml 394 400 394 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE12 </italic>
###xml 586 588 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 589 591 585 587 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 740 742 736 738 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 976 990 972 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 1076 1078 1072 1074 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1191 1199 1187 1195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1200 1201 1196 1197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1202 1204 1198 1200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 1233 1247 1229 1243 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 976 989 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 1191 1198 <span type="species:ncbi:562">E. coli</span>
###xml 1227 1232 <span type="species:ncbi:4932">yeast</span>
###xml 1233 1246 <span type="species:ncbi:4932">S. cerevisiae</span>
One interesting result from our study is that none of the genes involved in the control of base analogs sensitivity except two genes, YML013c-a and ade12, were found in screenings for genes controlling sensitivity to the other types of mutagens, MMS, UV, and ionizing radiation [23-27] or for elevated spontaneous mutagenesis [28]. It was previously reported that deletion of the YML013c-a and ADE12 open reading frame specifically enhanced sensitivity to killing (as in case of HAP) induced by gamma-radiation and bleomycin, but did not affect sensitivity to MMS, UV, and hydroxyurea [23,30]. It is known that there are overlaps of the sets of genes detected in genome screenings for the MMS-, UV- or ionizing radiation-sensitive strains [29]. Usually, those spectra include genes controlling DNA replication, recombination, and DNA repair. In our study, we did not find any of those genes. This is consistent with our earlier observation that the mutagenic action of HAP in S. cerevisiae does not depend on nucleotide excision repair, mutagenic repair, and mismatch repair [16]. A system to repair non-canonical purines and, probably HAP and AHA, in DNA has been recently characterized in E. coli [9,10]. It is possible that yeast S. cerevisiae lacks such a repair system.
###end p 37
###begin p 38
###xml 397 398 397 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 668 670 668 670 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 708 713 708 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fcy2 </italic>
###xml 1027 1032 1027 1032 <italic xmlns:xlink="http://www.w3.org/1999/xlink">APT1 </italic>
###xml 1140 1142 1140 1142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1463 1465 1463 1465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 39 44 <span type="species:ncbi:4932">yeast</span>
###xml 445 450 <span type="species:ncbi:4932">yeast</span>
###xml 661 666 <span type="species:ncbi:4932">yeast</span>
Based on our data, we propose that, in yeast, the major base analogs protective mechanism is a control of the quality of DNA precursor pool that prevents incorporation of base analogs into DNA. This mechanism may work at several levels: transport of analogs into cells, detoxification of analogs by metabolic enzymes, maintenance of nucleotide pools, and fidelity control of DNA replication (Fig. 4). HAP and AHA are likely transported into the yeast cell by the same permeases, which are involved in transport of natural purines. One candidate is purine-cytosine permease, Fcy2p, a major purine (adenine, guanine, and hypoxanthine) and cytosine transporter in yeast [31]. According to our unpublished data, fcy2 mutants are resistant to HAP. Thus, the active transport of HAP is the first critical step in the HAP mutagenic pathway. The next step is a conversion of the base analog to the corresponding ribonucleoside monophosphate by enzymes of the purine salvage pathway. Previously we observed that the inactivation of the APT1 gene, encoding adenine phosphoribosyl transferase, led to a severe decrease of the mutagenic effect of HAP [16], suggesting that this enzyme plays a key role in the biosynthesis of HAP-riboside-5'-monophosphate (HAPMP). HAPMP then may be converted to the corresponding nucleoside triphosphate, which could be ambiguously incorporated into DNA by DNA polymerases and provoke replication errors in the subsequent replication cycles [13].
###end p 38
###begin p 39
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 274 276 274 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 277 279 277 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 384 389 384 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAH1 </italic>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 607 615 607 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 685 687 685 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 708 715 708 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 747 752 747 752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AAH1 </italic>
###xml 883 888 883 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">aah1 </italic>
###xml 1034 1036 1034 1036 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 1041 1043 1041 1043 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3E</xref>
###xml 1051 1052 1051 1052 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 234 239 <span type="species:ncbi:4932">yeast</span>
###xml 640 645 <span type="species:ncbi:4932">yeast</span>
###xml 836 841 <span type="species:ncbi:4932">yeast</span>
The mechanism preventing HAP- and AHA-induced toxicity most likely involves the conversion of base analogs to non-mutagenic metabolites by purine salvage enzymes. The main argument for this hypothesis is that HAP could be utilized by yeast cells as a sole purine source [13,18,32]. The first enzyme in this HAP and AHA detoxification pathway is adenine aminohydrolase, encoded by the AAH1 gene. Aah1p from several microorganisms has been biochemically characterized (see [33]). Is has a broad substrate specificity and is capable of converting both adenine and its six-substituted analogs into hypoxanthine in vitro. According to our data, yeast Aah1p may convert HAP to hypoxanthine [12] and AHA to guanine in vivo, since the inactivation of the AAH1 leads to a defect in this conversion that is readily detected by UV spectroscopy of yeast medium (unpublished observation). In the aah1 mutant, the base analog intracellular concentration increases. We propose that this causes the elevation of base analog-induced mutagenesis (Fig. 3B and 3E, Table 1).
###end p 39
###begin p 40
###xml 54 59 54 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">amd1 </italic>
###xml 141 143 141 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B34">34</xref>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kanMX </italic>
###xml 493 498 493 498 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMD1 </italic>
###xml 202 207 <span type="species:ncbi:4932">yeast</span>
###xml 506 511 <span type="species:ncbi:4932">yeast</span>
###xml 552 557 <span type="species:ncbi:4932">yeast</span>
Interestingly, in our screening we did not detect the amd1 mutant, deficient in AMP aminohydrolase, that catalyze deamination of AMP to IMP [34]. We disrupted this gene by the kanMX cassette in several yeast strains and did not see any effect on HAP-induced mutagenesis anywhere. Thus, deamination of HAP at the mononucleotide level does not play an important role in HAP detoxification. This can be due to several reasons: the inability of the Amd1p to hydrolyse HAPMP, the minor role of the AMD1 gene in yeast, or the short life-time of the HAPMP in yeast cells.
###end p 40
###begin p 41
###xml 92 98 92 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE12 </italic>
###xml 179 181 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 186 188 186 188 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3F</xref>
###xml 200 201 200 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 308 316 308 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 322 323 322 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 588 594 588 594 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12 </italic>
###xml 689 697 689 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 907 913 907 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade12 </italic>
###xml 1085 1086 1085 1086 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 1184 1192 1184 1192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 1194 1202 1194 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli </italic>
###xml 1511 1513 1511 1513 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1514 1516 1514 1516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 1523 1530 1523 1530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E. coli</italic>
###xml 1536 1541 1536 1541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">rdgB </italic>
###xml 1579 1583 1579 1583 <italic xmlns:xlink="http://www.w3.org/1999/xlink">recA</italic>
###xml 1960 1961 1960 1961 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1194 1201 <span type="species:ncbi:562">E. coli</span>
###xml 1523 1530 <span type="species:ncbi:562">E. coli</span>
###xml 1919 1924 <span type="species:ncbi:4932">yeast</span>
We have found that inactivation of adenilosuccinate synthase (ASS or Ade12p) encoded by the ADE12 gene strongly enhanced HAP-induced mutagenesis and AHA-induced killing (see Fig. 3B and 3F, and Table 1). The primary function of this enzyme is the conversion of IMP to SAMP in the pathway of AMP biosynthesis de novo (Fig. 4). We propose that the reason for this hypersensitivity is the dysregulation of purine biosynthesis, as follows. First, the blocking of this step of purine biosynthesis causes accumulation of IMP in the cell. The excess of IMP is probably toxic for the cell, since ade12 mutants have a slow-growth phenotype that can be rescued by blocks of the earlier steps of the de novo purine biosynthesis pathway (Dr. A. M. Zekhnov {St-Petersburg State University}, personal communication). Accumulated IMP can be phosphorylated to ITP by nucleotide phosporylases. Thus, we propose that, in the ade12 mutant, an excess of ITP may saturate Ham1p triphosphatase, an essential enzyme for the destruction of HAPTP and dHAPTP, which leads to increased HAP-sensitivity (see Fig. 3). The data obtained recently in bacteria are consistent with this hypothesis. It was shown that, in vitro, E. coli Ham1p homologues protein, RdgB, is a triphosphatase that acts to hydrolize non-canonical DNA precursors, dIPT and dXTP. The Ham1p protein was shown to possess a similar activity on dITP, dXTP, and dHAPTP substrates (Kozmin and Pavlov, unpublished; Burgis and Cunnigham, personal communication; and see refs. [19-21]). In E. coli, the rdgB mutation is synthetically lethal with recA. As proposed, absence of RdgB leads to a dramatic increase of hypoxanthine and xanthine in DNA. Accordingly, base excision repair of such modified bases occurring in opposite strands may generate double strand breaks that require the RecA function to be repaired. However, over-expression of adenilosuccinate synthase PurA (homolog of yeast Ade12p) suppresses this lethality [9]. This suggests a critical role of ASS in the regulation of intracellular concentration of genotoxic hypoxanthine-containing nucleotides.
###end p 41
###begin p 42
###xml 59 67 59 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 106 107 106 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 224 241 224 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1</xref>
###xml 251 252 251 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 399 407 399 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B35">35</xref>
###xml 891 896 891 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade3 </italic>
###xml 902 903 902 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 914 915 914 915 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 922 927 922 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE3 </italic>
###xml 1164 1165 1164 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 1207 1219 1207 1219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade4, ade16 </italic>
###xml 1223 1229 1223 1229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade17 </italic>
###xml 1357 1365 1357 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 1407 1412 1407 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE4 </italic>
###xml 1473 1478 1473 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE4 </italic>
###xml 1653 1658 1653 1658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade4 </italic>
###xml 1678 1684 1678 1684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade16 </italic>
###xml 1688 1694 1688 1694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ade17 </italic>
###xml 1753 1759 1753 1759 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE16 </italic>
###xml 1763 1769 1763 1769 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ADE17 </italic>
We found that certain mutations affecting IMP biosynthesis de novo enhance HAP-induced mutagenesis (Table 1). Seven of sixteen newly identified genes controlling HAP and AHA sensitivity are involved in AMP biosynthesis (see Additional file 1 and Fig. 3). It is known that the regulation of the AMP biosynthesis pathway by adenine is mediated by SAICAR, one of the precursors in adenine biosynthesis de novo [35]. The accumulation of certain purine biosynthesis by-products may play a role in the regulation of the nucleotide pool. A defect in endogenous purine biosynthesis probably alters nucleotide pools to favour dHAPTP mis-incorporation into DNA or leads to HAP toxicity. In respect to this hypothesis, it is important that there is a difference in the level of HAP-induced mutagenesis among the strains carrying mutations in the genes of AMP biosynthesis. The less sensitive mutant is ade3 (Fig. 3 and Table 1). The ADE3 does not directly control any steps of purine biosynthesis. It encodes the C1-tetrahydrofolate synthase that provides C1-tetrahydrofolate, an indispensable precursor for AMP, histidine, thymidylate, and methionine biosynthesis (see Fig. 4). In this respect it is of interest that ade4, ade16 and ade17 mutants, also defective in IMP biosynthesis, were not found in our screen and were not sensitive to HAP or AHA when constructed de novo and tested directly (data not shown). The ADE4 stands apart because PRPP, a substrate of the product of the ADE4 gene, serves as a precursor for additional biosynthetic pathways. This prevents by-product accumulation and might be one of the explanations of lack of HAP sensitivity of the ade4 mutants. The single ade16 and ade17 mutants also do not lead to byproduct accumulation because ADE16 and ADE17 are isozymes and the inactivation of one gene does not block the pathway.
###end p 42
###begin p 43
###xml 39 47 39 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 56 80 56 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 0 80 0 80 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Purine salvage and purine biosynthesis <italic>de novo </italic>in yeast <italic>Saccharomyces cerevisiae</italic></bold>
###xml 123 131 123 131 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo </italic>
###xml 556 563 556 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">de novo</italic>
###xml 709 710 702 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 756 757 749 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 908 909 901 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 50 55 <span type="species:ncbi:4932">yeast</span>
###xml 56 80 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Purine salvage and purine biosynthesis de novo in yeast Saccharomyces cerevisiae. Intermediates of the purine biosynthesis de novo are designated in blue. The salvage pathway is presented in black. Genes, whose deletions lead to HAP and/or AHA sensitivity are highlighted by red boxes. The proposed conversions of HAP and AHA are represented in brackets below the adenine and guanine metabolites, respectively. Dashed arrows represent hypothetical pathways that were not demonstrated experimentally for a given substrate. Abbreviations:Purine biosynthesis de novo: PRPP - 5-phospho-ribosyl-1alpha-pyrophosphate, PRA - 5-phospho-beta-D-ribosylamine, GAR - 5-phosphoribosylglycinamide, FGAR - 5'-phosphoribosyl-N-formyl glycinamide, FGAM - 5'-phosphoribosyl-N-formylglycinamidine, AIR - 5'-phosphoribosyl-5-aminoimidazole, CAIR - 5'-phosphoribosyl-5-aminoimidazole-4-carboxylate, SAICAR - 5'-phosphoribosyl-4-(N-succinocarboxamide)-5-aminoimidazole, AICAR - 5'-phosphoribosyl-4-carboxamide-5-aminoimidazole, FAICAR - 5'-phosphoribosyl-4-carboxamide-5-formamidoimidazole, SAMP - adenylosuccinate, 5,10-methylene-THF - 5,10-methylenetetrahydrofolate, 10-formyl-THF - 10-formyltetrahydrofolate. Salvage: Ade - adenine, AdeRib - adenosine, Hyp - hypoxanthine, Gua - guanine, Xan - xanthine.
###end p 43
###begin p 44
###xml 54 92 54 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink">VIP1, VID27, IPK1, YGR035c, YML013c-a </italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SHE4</italic>
###xml 206 223 206 223 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1</xref>
We have found that 6 genes detected in our screening, VIP1, VID27, IPK1, YGR035c, YML013c-a and SHE4, are putatively involved in cell organization or genetically interact with cell-cycle control genes (see Additional file 1). This observation provides new perspectives on the mechanisms of base analogs-induced mutagenesis. It is possible that there is a specific structural route, mediated by cell cycle and cytoskeleton components, initiated by penetration of the analog inside the cell to its final target. We have also identified several hypothetical genes critical for the HAP and/or AHA resistance. This may be an initial clue to their functional significance.
###end p 44
###begin p 45
###xml 273 290 273 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="supplementary-material" rid="S1">Additional file 1</xref>
###xml 253 259 <span type="species:ncbi:9606">humans</span>
Finally, we would like to mention that out of the 18 genes we found to be involved in HAP and AHA sensitivity control, 11 (60%) have orthologs in all groups of organisms, including mammals. Therefore, the results have relevance to higher eukaryotes and humans as well (see Additional file 1).
###end p 45
###begin title 46
Conclusion
###end title 46
###begin p 47
We identified novel mutants sensitive to mutagenic and toxic effects of purine base analogs. AHA sensitivity was not previously described for three of the mutants identified in this study. The results reveal a complex control of base analogue mutagenesis by genes encoding the components of metabolic pathways and cytoskeleton.
###end p 47
###begin title 48
Methods
###end title 48
###begin title 49
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast strains and media
###end title 49
###begin p 50
###xml 28 42 28 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. cerevisiae </italic>
###xml 133 178 133 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MAT&#945; his3&#916;leu2&#916;lys2&#916;ura3&#916;</italic>
###xml 352 359 332 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink">kanMX4 </italic>
###xml 408 410 388 390 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B36">36</xref>
###xml 28 41 <span type="species:ncbi:4932">S. cerevisiae</span>
###xml 250 255 <span type="species:ncbi:4932">Yeast</span>
We have used a set of 4,823 S. cerevisiae mutants carrying deletions of all non-essential ORFs created in the haploid strain BY4742 (MATalpha his3Deltaleu2Deltalys2Deltaura3Delta). The information about the deletion strains set is available from the Yeast Deletion Project site: . Deletion strains were constructed by replacement of the ORF's with the kanMX4 cassette, which confers resistance to geneticin [36].
###end p 50
###begin p 51
###xml 84 86 84 86 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 386 388 381 383 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
###xml 13 18 <span type="species:ncbi:4932">yeast</span>
The standard yeast complete media (YPD) and minimal synthetic media (SD) were used [37]. Deletion strains were cultivated on YPD medium, supplemented with 200 mug/ml of geneticin. Sensitivity to HAP and AHA was examined on YPD media containing analogs in concentrations 100 mug/ml, 10 mug/ml and 1 mug/ml. SD medium containing 40 mug/ml of L-canavanine was used for the selection of Canr mutants.
###end p 51
###begin title 52
Base analogs sensitivity tests
###end title 52
###begin p 53
###xml 216 218 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 435 436 434 435 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 558 560 551 553 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8 </sup>
###xml 786 787 778 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
###xml 969 971 961 963 <sup xmlns:xlink="http://www.w3.org/1999/xlink">r </sup>
HAP was purchased from MP Biomedicals (Irvine, California, USA). AHA was custom- synthesized by Dr. I. Kuchuk at the Department of Chemistry of Indiana University (Bloomington, Indiana, USA) by the method of Janion [38]. Both chemicals were dissolved in DMSO (Fisher, USA) with mild heating. A single colony of each tested strain was inoculated into a well of 96-well microtitre plate containing 200 mul of liquid YPD medium (see Fig. 2). Microtiter plates were incubated for 2 days at 30degreesC with agitation, to reach a stationary phase (approximately 108 cells/ml). For mutagenesis assay, cells were then plated by a multiprong replicator device (approximately 5 mul of cell suspension per prong) to the YPD plates containing various concentrations of HAP or AHA, as shown on Fig. 2. After one day of incubation, the plates were replica-plated on SD minimal-medium plates containing L-canavanine. The plates were incubated 5 days and inspected for induction of Canr mutants.
###end p 53
###begin p 54
###xml 152 153 152 153 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2</xref>
For the survival test, cell cultures from the microplates were diluted in water in series of 96-well microplates, using a multichanel pipette (see Fig. 2). Diluted cells suspensions were plated to YPD plates containing HAP or AHA by a multiprong replicator device. After 2-3 days of incubation, the number of colonies was recorded. Strains that produced smaller colonies or a smaller number of colonies on the HAP-containing medium, relatively to wild-type strain, were classified as sensitive to killing.
###end p 54
###begin title 55
Quantitative assay of the base analog-induced mutagenesis
###end title 55
###begin p 56
###xml 588 590 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
For each strain and each concentration of base analogs to be tested, we prepared six independent cultures by inoculating a single colony into 1 ml of liquid YPD medium with or without mutagens. After two days incubation in the roller drum, the mutant frequencies were determined by plating of appropriately diluted cell suspensions on minimal-medium SD plates supplemented with L-canavanine (to determine the number of canavanine-resistant cells per culture), and on YPD plates (to obtain the total number of cells per culture). Then the frequency of mutants was calculated as described [14]. Each experiment was repeated at least three times. We have used several doses of HAP and found that in this type of test the most reproducible results are obtained at dose 25 mug/ml. The statistical significance of differences between variants was estimated by Wilcoxon-Mann-Whitney nonparametric criterion.
###end p 56
###begin title 57
Authors' contributions
###end title 57
###begin p 58
Youri Pavlov and Elena Stepchenkova designed this study. Elena Stepchenkova performed the experimental work and wrote the initial draft of the manuscript. Vladimir Alenin, Youri Pavlov, Stanislav Kozmin, and Elena Stepchenkova analyzed the data set and wrote the final version of the paper.
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
Additional File 1
###end title 60
###begin p 61
Annotation of the genes whose deletion results in HAP and AHA sensitivity
###end p 61
###begin p 62
Click here for file
###end p 62
###begin title 63
Acknowledgements
###end title 63
###begin p 64
We are grateful to Polina Shcherbakova for comments during this study and for critical reading of the manuscript. This work was supported in part, by NE DHHS LB506 grant #9934 for YIP, and by the CRDF grant provided by The Russian Ministry of Education # ST-012-0.
###end p 64
###begin article-title 65
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 0 16 <span type="species:ncbi:562">Escherichia coli</span>
Escherichia coli mutants deficient in deoxyuridine triphosphatase
###end article-title 65
###begin article-title 66
The GO system protects organisms from the mutagenic effect of the spontaneous lesion 8-hydroxyguanine (7,8-dihydro-8-oxoguanine)
###end article-title 66
###begin article-title 67
Mutagenesis by 8-oxoguanine: an enemy within
###end article-title 67
###begin article-title 68
Mutagenic potentials of damaged nucleic acids produced by reactive oxygen/nitrogen species: approaches using synthetic oligonucleotides and nucleotides: survey and summary
###end article-title 68
###begin article-title 69
MutT protein specifically hydrolyses a potent mutagenic substrate for DNA synthesis
###end article-title 69
###begin article-title 70
###xml 75 144 75 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli, Salmonella typhimurium and Saccharomyces cerevisiae</italic>
###xml 75 91 <span type="species:ncbi:562">Escherichia coli</span>
###xml 93 115 <span type="species:ncbi:90371">Salmonella typhimurium</span>
###xml 120 144 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The genetic activity of N6-hydroxyadenine and 2-amino-N6-hydroxyadenine in Escherichia coli, Salmonella typhimurium and Saccharomyces cerevisiae
###end article-title 70
###begin article-title 71
The genetic toxicology of 2-amino-N6-hydroxyadenine in eukaryotic organisms: significance for genetic risk assessment
###end article-title 71
###begin article-title 72
Oxidation of DNA bases, deoxyribonucleosides and homopolymers by peroxyl radicals
###end article-title 72
###begin article-title 73
###xml 42 58 42 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 42 58 <span type="species:ncbi:562">Escherichia coli</span>
Repair system for noncanonical purines in Escherichia coli
###end article-title 73
###begin article-title 74
###xml 47 63 <span type="species:ncbi:562">Escherichia coli</span>
RdgB acts to avoid chromosome fragmentation in Escherichia coli
###end article-title 74
###begin article-title 75
###xml 26 43 26 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli </italic>
###xml 26 42 <span type="species:ncbi:562">Escherichia coli</span>
RecA-dependent mutants in Escherichia coli reveal strategies to avoid chromosomal fragmentation
###end article-title 75
###begin article-title 76
###xml 63 68 <span type="species:ncbi:4932">yeast</span>
Mutagenicity of 5-bromouracil and N6-hydroxyadenine studied by yeast oligonucleotide transformation assay
###end article-title 76
###begin article-title 77
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HAM1</italic>
###xml 92 116 92 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 86 91 <span type="species:ncbi:4932">yeast</span>
###xml 92 116 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
HAM1, the gene controlling 6-N-hydroxylaminopurine sensitivity and mutagenesis in the yeast Saccharomyces cerevisiae
###end article-title 77
###begin article-title 78
###xml 61 86 61 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 55 60 <span type="species:ncbi:4932">yeast</span>
###xml 61 85 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Base analog 6-N-hydroxylaminopurine mutagenesis in the yeast Saccharomyces cerevisiae is controlled by replicative DNA polymerases
###end article-title 78
###begin article-title 79
###xml 135 159 135 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 135 159 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
3'->5' exonucleases of DNA polymerases epsilon and delta correct base analog induced DNA replication errors on opposite DNA strands in Saccharomyces cerevisiae
###end article-title 79
###begin article-title 80
###xml 137 142 <span type="species:ncbi:4932">yeast</span>
Multiple antimutagenesis mechanisms affect mutagenic activity and specificity of the base analog 6-N-hydroxylaminopurine in bacteria and yeast
###end article-title 80
###begin article-title 81
###xml 20 53 20 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli &#916;(uvrB-bio) </italic>
###xml 20 36 <span type="species:ncbi:562">Escherichia coli</span>
Hypersensitivity of Escherichia coli Delta(uvrB-bio) mutants to 6-hydroxylaminopurine and other base analogs is due to a defect in molybdenum cofactor biosynthesis
###end article-title 81
###begin article-title 82
###xml 12 37 12 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 12 36 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
[Mutants of Saccharomyces cerevisiae supersensitive to the mutagenic effect of 6-N-hydroxylaminopurine]
###end article-title 82
###begin article-title 83
###xml 54 78 54 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Methanococcus jannaschii</italic>
###xml 54 78 <span type="species:ncbi:2190">Methanococcus jannaschii</span>
Structure-based identification of a novel NTPase from Methanococcus jannaschii
###end article-title 83
###begin article-title 84
###xml 61 77 61 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Escherichia coli</italic>
###xml 61 77 <span type="species:ncbi:562">Escherichia coli</span>
Identification of the dITP- and XTP-hydrolyzing protein from Escherichia coli
###end article-title 84
###begin article-title 85
###xml 105 110 105 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITPA </italic>
###xml 47 52 <span type="species:ncbi:9606">human</span>
Cloning, expression, and characterization of a human inosine triphosphate pyrophosphatase encoded by the ITPA gene
###end article-title 85
###begin article-title 86
###xml 28 53 28 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 28 52 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Functional profiling of the Saccharomyces cerevisiae genome
###end article-title 86
###begin article-title 87
###xml 52 57 <span type="species:ncbi:4932">yeast</span>
Genes required for ionizing radiation resistance in yeast
###end article-title 87
###begin article-title 88
###xml 24 49 24 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 24 48 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A genome-wide screen in Saccharomyces cerevisiae for genes affecting UV radiation sensitivity
###end article-title 88
###begin article-title 89
A genome-wide screen for methyl methanesulfonate-sensitive mutants reveals genes required for S phase progression in the presence of DNA damage
###end article-title 89
###begin article-title 90
###xml 79 104 79 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 79 103 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Use of a genome-wide approach to identify new genes that control resistance of Saccharomyces cerevisiae to ionizing radiation
###end article-title 90
###begin article-title 91
###xml 62 67 <span type="species:ncbi:4932">yeast</span>
Genome-wide analysis of iron-dependent growth reveals a novel yeast gene required for vacuolar acidification
###end article-title 91
###begin article-title 92
###xml 23 48 23 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 23 47 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
A genomewide screen in Saccharomyces cerevisiae for genes that suppress the accumulation of mutations
###end article-title 92
###begin article-title 93
Network responses to DNA damaging agents
###end article-title 93
###begin article-title 94
###xml 114 138 114 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 114 138 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Cell cycle progression in G1 and S phases is CCR4 dependent following ionizing radiation or replication stress in Saccharomyces cerevisiae
###end article-title 94
###begin article-title 95
###xml 37 62 37 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 118 123 118 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink">FCY2 </italic>
###xml 37 61 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
The purine-cytosine permease gene of Saccharomyces cerevisiae : primary structure and deduced protein sequence of the FCY2 gene product
###end article-title 95
###begin article-title 96
###xml 89 114 89 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae </italic>
###xml 89 113 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
###xml 114 120 <span type="species:ncbi:4932">yeasts</span>
[Genetic control of metabolism of a mutagenic analog of 6-N-hydroxylaminopurine bases in Saccharomyces cerevisiae yeasts]
###end article-title 96
###begin article-title 97
Adenine aminohydrolase. An investigation of specificity
###end article-title 97
###begin article-title 98
###xml 43 69 43 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Schizosaccharomyces pombe </italic>
###xml 97 121 97 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
###xml 43 68 <span type="species:ncbi:4896">Schizosaccharomyces pombe</span>
###xml 97 121 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
Yeast AMP deaminase. Catalytic activity in Schizosaccharomyces pombe and chromosomal location in Saccharomyces cerevisiae
###end article-title 98
###begin article-title 99
###xml 0 5 <span type="species:ncbi:4932">Yeast</span>
Yeast AMP pathway genes respond to adenine through regulated synthesis of a metabolic intermediate
###end article-title 99
###begin article-title 100
###xml 72 96 72 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Saccharomyces cerevisiae</italic>
###xml 72 96 <span type="species:ncbi:4932">Saccharomyces cerevisiae</span>
New heterologous modules for classical or PCR-based gene disruptions in Saccharomyces cerevisiae
###end article-title 100
###begin article-title 101
The synthesis and properties of N6-substituted 2-amino-purine derivatives
###end article-title 101

